October 27, 2026

Patient Advocacy and Support

A Paradigm Shift in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research a-paradigm-shift-in-oncology-karen-and-rob-hale-commit-record-breaking-50-million-to-breast-cancer-research

A Paradigm Shift in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research

Pevita Pearce October 18, 2026
NEW YORK, NY – In a move that signals a new era for oncological philanthropy and scientific...
Read More Read more about A Paradigm Shift in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research
A New Era in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research Foundation a-new-era-in-oncology-karen-and-rob-hale-commit-record-breaking-50-million-to-breast-cancer-research-foundation

A New Era in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research Foundation

Muslim October 18, 2026
NEW YORK, NY — In a move that marks a definitive turning point in the global fight...
Read More Read more about A New Era in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research Foundation
Navigating the "New Normal": Breast Cancer Canada Addresses the Long-Term Realities of Survivorship navigating-the-new-normal-breast-cancer-canada-addresses-the-long-term-realities-of-survivorship

Navigating the "New Normal": Breast Cancer Canada Addresses the Long-Term Realities of Survivorship

Iffa Jayyana October 18, 2026
TORONTO, ON – As medical advancements continue to improve survival rates for breast cancer patients, a secondary...
Read More Read more about Navigating the "New Normal": Breast Cancer Canada Addresses the Long-Term Realities of Survivorship
Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Emerging Research and Patient Concerns navigating-the-nexus-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research-and-patient-concerns

Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Emerging Research and Patient Concerns

Layla Zulfa October 17, 2026
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) In recent years, Glucagon-like peptide-1 (GLP-1)...
Read More Read more about Navigating the Nexus: GLP-1 Medications and Breast Cancer – A Deep Dive into Emerging Research and Patient Concerns
A Paradigm Shift in Oncology: Karen and Rob Hale Commit Historic $50 Million to Breast Cancer Research Foundation a-paradigm-shift-in-oncology-karen-and-rob-hale-commit-historic-50-million-to-breast-cancer-research-foundation

A Paradigm Shift in Oncology: Karen and Rob Hale Commit Historic $50 Million to Breast Cancer Research Foundation

Ali Ikhwan October 17, 2026
NEW YORK, NY – In a move that signals a new era for oncological philanthropy, Karen and...
Read More Read more about A Paradigm Shift in Oncology: Karen and Rob Hale Commit Historic $50 Million to Breast Cancer Research Foundation

You may have missed

a-new-era-in-prostate-cancer-treatment-dual-action-therapy-targets-genetic-weaknesses-offering-significant-hope

A New Era in Prostate Cancer Treatment: Dual-Action Therapy Targets Genetic Weaknesses, Offering Significant Hope

Nana Wu October 27, 2026
unlocking-tension-an-8-minute-guide-to-rejuvenating-your-hips

Unlocking Tension: An 8-Minute Guide to Rejuvenating Your Hips

Evan Lee Salim October 27, 2026
a-journey-through-grief-and-identity-how-one-life-found-new-meaning-through-community-support

A Journey Through Grief and Identity: How One Life Found New Meaning Through Community Support

Nana October 27, 2026
the-fragility-of-time-a-daughters-journey-from-estrangement-to-reconciliation

The Fragility of Time: A Daughter’s Journey from Estrangement to Reconciliation

Lina Irawan October 27, 2026